N
ATRC icon

Natixis’s AtriCure ATRC Stock Holding History

Natixis’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-18,800
Closed -$616K – 1073
2025
Q2 		$616K Hold
18,800
– – ﹤0.01% 686
2025
Q1 		$608K Sell
18,800
-41,700
-69% -$1.55M ﹤0.01% 636
2024
Q4 		$1.85M Buy
+60,500
New +$1.95M 0.01% 484
2024
Q2 		– Sell
-300,000
Closed -$9.13M – 1002
2024
Q1 		$9.13M Buy
+300,000
New +$10M 0.05% 246

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Natixis's ATRC Position: Q3 2025 in Review

Natixis sold out of AtriCure (ATRC) in Q3 2025, closing a stake of 18,800 shares — an estimated $616K sold.

Natixis first reported a position in ATRC in Q1 2024 and held it in 4 quarters. The position peaked at $9.13M in Q1 2024. 223 funds tracked by Wall St. Rank hold ATRC as of Q3 2025.

  • Natixis reported no remaining AtriCure position as of Q3 2025 after selling out during the quarter.
  • Natixis sold 18,800 AtriCure shares in Q3 2025, an estimated $616K.
  • Natixis first reported a position in AtriCure in Q1 2024 and held it in 4 quarters.
  • Natixis's AtriCure position peaked at $9.13M in Q1 2024.
  • 223 funds tracked by Wall St. Rank held AtriCure as of Q3 2025.

Based on Natixis's 13F filing for Q3 2025, filed 14 Nov 2025.